United States· US:0220-2931_f9155d23-35bf-0802-e053-6294a90a50af
Kalmia latifolia
A medicinal product containing kalmia latifolia leaf, registered in United States by Boiron.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- KALMIA LATIFOLIA LEAF
- Manufacturer
- Boiron
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11022029314130 [hp_C] in 1 TUBE (0220-2931-41)
- ndc110220-2931-41
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Kalmia latifolia leaf in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be8bc122-1ee6-420f-a226-ea972b01ae66 GET /v1/drugs/be8bc122-1ee6-420f-a226-ea972b01ae66?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "30",
"substance": "KALMIA LATIFOLIA LEAF",
"productndc": "0220-2931",
"dosage_form": "PELLET",
"dea_schedule": null,
"strength_unit": "[hp_C]/30[hp_C]",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about kalmia latifolia leaf.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.